000119819 001__ 119819
000119819 005__ 20240319081004.0
000119819 0247_ $$2doi$$a10.1177/17562848221117636
000119819 0248_ $$2sideral$$a130763
000119819 037__ $$aART-2022-130763
000119819 041__ $$aeng
000119819 100__ $$aDomper-Arnal, María José$$uUniversidad de Zaragoza
000119819 245__ $$aThe impact of COVID-19 pandemic in the diagnosis and management of colorectal cancer patients
000119819 260__ $$c2022
000119819 5060_ $$aAccess copy available to the general public$$fUnrestricted
000119819 5203_ $$aThe novel coronavirus disease 2019 (COVID-19) pandemic has posed an unprecedented challenge to healthcare systems worldwide, causing downscaling of almost all other activities, especially in its early stages. Currently, the availability of vaccines along with the spread of new viral variants has modified the epidemiology of the disease, and the previous activity is being gradually resumed in most healthcare facilities. In this review, we have summarized the influence of the COVID-19 pandemic in the diagnosis and management of colorectal cancer (CRC) patients. Population-based screening with either colonoscopy or fecal occult blood tests has proven to reduce CRC incidence and mortality, so screening programs have been implemented in most western countries. However, during the first COVID-19 wave, most of these programs had to be disrupted temporarily. In this review, we have thoroughly analyzed the consequences of these disruptions of screening programs as well as of the forced delays in diagnostic and therapeutic services on CRC prognosis, although its exact impact cannot be exactly measured yet. In any way, strategies to minimize its effect, such as catch-up strategies expanding the colonoscopy capacity or using fecal occult blood concentration and other risk factors to prioritize patients, are urgently needed. The COVID-19 pandemic has also led to a change in CRC patient presentation, with an overall temporary decreased incidence due to postponed diagnoses, but with more patients presenting in need of an emergency admission or with symptoms. Finally, changes in treatment approaches in CRC patients have been reported during the pandemic, namely a drop in the proportion of laparoscopic surgeries or a rise in short-term radiotherapy courses. We have therefore aimed to summarize the available evidence to guide the healthcare professionals treating CRC patients to choose the best treatment options in the current pandemic situation.
000119819 540__ $$9info:eu-repo/semantics/openAccess$$aby-nc$$uhttp://creativecommons.org/licenses/by-nc/3.0/es/
000119819 590__ $$a4.2$$b2022
000119819 592__ $$a1.226$$b2022
000119819 591__ $$aGASTROENTEROLOGY & HEPATOLOGY$$b34 / 93 = 0.366$$c2022$$dQ2$$eT2
000119819 593__ $$aGastroenterology$$c2022$$dQ1
000119819 594__ $$a6.6$$b2022
000119819 655_4 $$ainfo:eu-repo/semantics/review$$vinfo:eu-repo/semantics/publishedVersion
000119819 700__ $$aHijos-Mallada, Gonzalo$$uUniversidad de Zaragoza
000119819 700__ $$0(orcid)0000-0001-5932-2889$$aLanas, Ángel$$uUniversidad de Zaragoza
000119819 7102_ $$11007$$2610$$aUniversidad de Zaragoza$$bDpto. Medicina, Psiqu. y Derm.$$cArea Medicina
000119819 773__ $$g15 (2022), [13 pp.]$$pTherap. adv. in gastroenterol.$$tTherapeutic Advances in Gastroenterology$$x1756-283X
000119819 8564_ $$s721524$$uhttps://zaguan.unizar.es/record/119819/files/texto_completo.pdf$$yVersión publicada
000119819 8564_ $$s2988410$$uhttps://zaguan.unizar.es/record/119819/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000119819 909CO $$ooai:zaguan.unizar.es:119819$$particulos$$pdriver
000119819 951__ $$a2024-03-18-14:29:18
000119819 980__ $$aARTICLE